Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells
Diu Nguyen, Yuheng Lu, Eren L. Chu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia
Eric Wang, Sydney X. Lu, Alessandro Pastore, et al.
Cancer Cell (2019) Vol. 35, Iss. 3, pp. 369-384.e7
Open Access | Times Cited: 288
N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation
Yuanming Cheng, Wei Xie, Brian F. Pickering, et al.
Cancer Cell (2021) Vol. 39, Iss. 7, pp. 958-972.e8
Open Access | Times Cited: 181
Robust single-cell discovery of RNA targets of RNA-binding proteins and ribosomes
Kristopher W. Brannan, Isaac A. Chaim, Ryan J. Marina, et al.
Nature Methods (2021) Vol. 18, Iss. 5, pp. 507-519
Open Access | Times Cited: 114
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Zhen Zeng, Minyang Fu, Yuan Hu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 59
Principles of mRNA targeting via the Arabidopsis m6A-binding protein ECT2
Laura Arribas‐Hernández, Sarah Rennie, Tino Köster, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 61
Profiling of RNA-binding protein binding sites by in situ reverse transcription-based sequencing
Yu Xiao, Yan-Ming Chen, Zhongyu Zou, et al.
Nature Methods (2024) Vol. 21, Iss. 2, pp. 247-258
Open Access | Times Cited: 11
Improving bulk RNA-seq classification by transferring gene signature from single cells in acute myeloid leukemia
Ran Wang, Xubin Zheng, Jun Wang, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 2
Closed Access | Times Cited: 32
TRIBE editing reveals specific mRNA targets of eIF4E-BP in Drosophila and in mammals
Hua Jin, Weijin Xu, Reazur Rahman, et al.
Science Advances (2020) Vol. 6, Iss. 33
Open Access | Times Cited: 39
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
Petr Makhov, Igor Bychkov, Bulat Faezov, et al.
Oncogenesis (2021) Vol. 10, Iss. 3
Open Access | Times Cited: 29
RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoietic stem and progenitor cells
Florisela Herrejon Chavez, Hanzhi Luo, Paolo Cifani, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Myofibroblast‐Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model
Chen Qu, Lu He, Nan Yao, et al.
Hepatology (2021) Vol. 74, Iss. 1, pp. 458-473
Closed Access | Times Cited: 25
Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemia
Jingliao Zhang, Yong-Juan Duan, Peng Wu, et al.
Blood (2023) Vol. 143, Iss. 4, pp. 320-335
Closed Access | Times Cited: 10
Transcriptome reprogramming through alternative splicing triggered by apigenin drives cell death in triple-negative breast cancer
Meenakshi Sudhakaran, Tatiana García Navarrete, Katherine Mejía-Guerra, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 10
Altered RNA-processing provides a mechanistic framework delineating human sex reversal associated with pathogenic variants in the RNA-helicase DHX37
Maëva Elzaïat, Estelle Talouarn, Somboon Wankanit, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Intestinal stem cell marker MEX3A regulates PPARγ expression with functional impact in colorectal carcinogenesis
Ana Rita Silva, Alexandre Coelho, Vanessa Machado, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Update on the Progress of Musashi-2 in Malignant Tumors
Yulian Niu, Tao Zhou, Yanjun Li
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 1
Open Access
β-Catenin interacts with a Wnt signaling mRNA network in myeloid leukaemia cells through canonical RBP binding.
Gareth Morgan, Megan Wagstaff, Okan Sevim, et al.
Research Square (Research Square) (2025)
Closed Access
The Super Enhancer‐Driven Long Noncoding RNA PRKCQ‐AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule Compounds
Sujanna Mondal, Pei Y. Liu, Janith A. Seneviratne, et al.
Advanced Science (2025)
Open Access
β-Catenin interacts with canonical RBPs including MSI2 to associate with a Wnt signalling mRNA network in myeloid leukaemia cells
Megan Payne, Okan Sevim, A.K. Goff, et al.
Oncogene (2025)
Open Access
Targeted RNA editing: novel tools to study post-transcriptional regulation
Weijin Xu, Jeetayu Biswas, Robert H. Singer, et al.
Molecular Cell (2021) Vol. 82, Iss. 2, pp. 389-403
Open Access | Times Cited: 21
Integrative genome-wide analysis reveals EIF3A as a key downstream regulator of translational repressor protein Musashi 2 (MSI2)
Shilpita Karmakar, Oscar Ramirez, Kiran Paul, et al.
NAR Cancer (2022) Vol. 4, Iss. 2
Open Access | Times Cited: 16
Comparison of TRIBE and STAMP for identifying targets of RNA binding proteins in human andDrosophilacells
Katharine C. Abruzzi, Corrie Ratner, Michael Rosbash
RNA (2023) Vol. 29, Iss. 8, pp. 1230-1242
Open Access | Times Cited: 9
Targeting RNA-binding proteins in acute and chronic leukemia
Irina Elcheva, Vladimir S. Spiegelman
Leukemia (2020) Vol. 35, Iss. 2, pp. 360-376
Open Access | Times Cited: 22
MUSASHI‐2 confers resistance to third‐generation EGFR‐tyrosine kinase inhibitor osimertinib in lung adenocarcinoma
Reheman Yiming, Yasuto Takeuchi, Tatsunori Nishimura, et al.
Cancer Science (2021) Vol. 112, Iss. 9, pp. 3810-3821
Open Access | Times Cited: 19
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
Tatiana Erazo, Chiara M. Evans, Daniel Zakheim, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top